Ravi Amaravadi

Ravi Amaravadi

University of Pennsylvania

H-index: 78

North America-United States

Contact Ravi Amaravadi

About Ravi Amaravadi

Ravi Amaravadi, With an exceptional h-index of 78 and a recent h-index of 66 (since 2020), a distinguished researcher at University of Pennsylvania,

His recent articles reflect a diverse array of research interests and contributions to the field:

FDG PET/CT Imaging 1 Week after a Single Dose of Pembrolizumab Predicts Treatment Response in Patients with Advanced Melanoma

Corrigendum to'Long-term outcomes to neoadjuvant pembrolizumab based on pathological response for patients with resectable stage III/IV cutaneous melanoma':[Annals of Oncology …

Author Correction: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials

HRS mediates tumor immune evasion by regulating proteostasis-associated interferon pathway activation

20th Anniversary of the Society for Melanoma Research: Celebrating two decades of progress in melanoma research

579-C Reinvigoration of progenitor-exhausted CD8 T cells by anti-CTLA-4 contributes to the sustained activity of combination checkpoint blockade

Upregulation of exosome secretion from tumor-associated macrophages plays a key role in the suppression of anti-tumor immunity

Long-term outcomes to neoadjuvant pembrolizumab based on pathological response for patients with resectable stage III/IV cutaneous melanoma

Ravi Amaravadi Information

University	University of Pennsylvania
Position	___
Citations(all)	46396
Citations(since 2020)	25702
Cited By	28934
hIndex(all)	78
hIndex(since 2020)	66
i10Index(all)	154
i10Index(since 2020)	130
Email	Access Email
University Profile Page	University of Pennsylvania
Google Scholar	View Google Scholar Profile

Top articles of Ravi Amaravadi

FDG PET/CT Imaging 1 Week after a Single Dose of Pembrolizumab Predicts Treatment Response in Patients with Advanced Melanoma

Clinical Cancer Research

2024/1/24

Alexander C Huang

H-Index: 17

Xiaowei Xu

H-Index: 12

Wei Xu

H-Index: 19

Corrigendum to'Long-term outcomes to neoadjuvant pembrolizumab based on pathological response for patients with resectable stage III/IV cutaneous melanoma':[Annals of Oncology …

Annals of oncology: official journal of the European Society for Medical Oncology

2024/4/13

Author Correction: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials

Nature communications

2024/2/5

Cathrine Axfors

H-Index: 8

Perrine Janiaud

H-Index: 12

Sherief Abd-Elsalam

H-Index: 20

Derek C Angus

H-Index: 92

Olav Dalgard

H-Index: 28

Lennie Derde

H-Index: 19

Yi-Chun Lin

H-Index: 11

Ahmad Mourad

H-Index: 7

Susanna Naggie

H-Index: 25

Muhammad Shahzad

H-Index: 3

Shaimaa Soliman

H-Index: 7

Nicholas A Turner

H-Index: 9

Maria Velinova

H-Index: 3

David Moher

H-Index: 118

HRS mediates tumor immune evasion by regulating proteostasis-associated interferon pathway activation

Cell reports

2023/11/28

Wei Zhang

H-Index: 23

Jiegang Yang

H-Index: 5

Youtao Lu

H-Index: 0

Jingbo Yang

H-Index: 3

Zhiyuan Qin

H-Index: 3

Ravi Amaravadi

H-Index: 58

Xiaowei Xu

H-Index: 12

Wei Guo

H-Index: 1

20th Anniversary of the Society for Melanoma Research: Celebrating two decades of progress in melanoma research

2023/11

Ravi Amaravadi

H-Index: 58

Andrew Aplin

H-Index: 32

Richard White

H-Index: 6

579-C Reinvigoration of progenitor-exhausted CD8 T cells by anti-CTLA-4 contributes to the sustained activity of combination checkpoint blockade

2023/11/1

Kevin Wang

H-Index: 2

David Brocks

H-Index: 13

Nicholas Han

H-Index: 4

Divij Mathew

H-Index: 10

Wei Xu

H-Index: 19

Xiaowei Xu

H-Index: 12

Marcus Buggert

H-Index: 21

Andy Minn

H-Index: 37

Upregulation of exosome secretion from tumor-associated macrophages plays a key role in the suppression of anti-tumor immunity

Cell reports

2023/10/31

Youtao Lu

H-Index: 0

Jingbo Yang

H-Index: 3

Zhiyuan Qin

H-Index: 3

Wei Zhang

H-Index: 23

Bin Wu

H-Index: 2

Shujing Liu

H-Index: 20

Wei Xu

H-Index: 19

Ravi Amaravadi

H-Index: 58

Min Xiao

H-Index: 10

Xiaowei Xu

H-Index: 12

Wei Guo

H-Index: 1

Long-term outcomes to neoadjuvant pembrolizumab based on pathological response for patients with resectable stage III/IV cutaneous melanoma

Annals of Oncology

2023/9/1

A Phase II Open-Label Trial of Binimetinib and Hydroxychloroquine in Patients With Advanced KRAS-Mutant Non-Small Cell Lung Cancer

The Oncologist

2023/7/1

Qi Long

H-Index: 29

Evan Anderson

H-Index: 37

Ravi Amaravadi

H-Index: 58

Safety and efficacy of hydroxychloroquine as prophylactic against COVID-19 in healthcare workers: a meta-analysis of randomised clinical trials

2023/6/1

Ravi Amaravadi

H-Index: 58

David R Boulware

H-Index: 47

Susanna Naggie

H-Index: 25

Radha Rajasingham

H-Index: 23

Five-year survival outcomes in patients with melanoma with complete response to immunotherapy who discontinue therapy.

2023/6/1

Patient-derived melanoma organoid models facilitate the assessment of immunotherapies

EBioMedicine

2023/6/1

Shujing Liu

H-Index: 20

Huaishan Wang

H-Index: 9

Lei Guan

H-Index: 5

Alexander C Huang

H-Index: 17

Ravi Amaravadi

H-Index: 58

Wei Guo

H-Index: 1

Jina Ko

H-Index: 10

Qing Chen

H-Index: 7

Bin Tian

H-Index: 7

Xiaowei Xu

H-Index: 12

Phase I trial of autologous RNA-electroporated cMET-directed CAR T cells administered intravenously in patients with melanoma and breast carcinoma

Cancer Research Communications

2023/5/9

Alexander C Huang

H-Index: 17

Xiaowei Xu

H-Index: 12

Julia Tchou

H-Index: 30

Amy Marshall

H-Index: 7

Andrea Brennan

H-Index: 7

Lysosomal lipid peroxidation regulates tumor immunity

The Journal of Clinical Investigation

2023/4/17

Vaibhav Jain

H-Index: 7

Seokwoo Lee

H-Index: 5

Masao Morita

H-Index: 13

Qin Liu

H-Index: 2

Recent advances in targeting autophagy in cancer

2023/3/15

Vaibhav Jain

H-Index: 7

Targeting UGCG overcomes resistance to lysosomal autophagy inhibition

Cancer discovery

2023/2/6

Vaibhav Jain

H-Index: 7

Qin Liu

H-Index: 2

Peroxynitrite in the tumor microenvironment changes the profile of antigens allowing escape from cancer immunotherapy

Cancer cell

2022/10/10

Ali Mostafa

H-Index: 5

Xiaowei Xu

H-Index: 12

Wei Xu

H-Index: 19

Zhe Yuan

H-Index: 17

Pumping iron: ferritinophagy promotes survival and therapy resistance in pancreatic cancer

Cancer discovery

2022/9/2

Vaibhav Jain

H-Index: 7

450O Initial monotherapy results of a phase I first-in-human study of ULK1/2 inhibitor DCC-3116 alone and in combination with MAPK pathway inhibition

Annals of Oncology

2022/9/1

Moderate colitis not requiring intravenous steroids is associated with improved survival in stage IV melanoma after anti-CTLA4 monotherapy, but not combination therapy

The Oncologist

2022/9/1

Brian Chu

H-Index: 3

Xiaoyan Han

H-Index: 2

Andrea Facciabene

H-Index: 18

See List of Professors in Ravi Amaravadi University(University of Pennsylvania)

academic-engine

Useful Links

List of top 50 universities

List of top 100 universities

List of top 500 universities

Find Professors Email

Find Universities Email

CUFinder Academic Engine